Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.08% | 132.19 | 0.0% | $1591.35m | |
| NVAX | Novavax, Inc. | 10.59% | 174.84 | 92.9% | $1076.02m | |
| OCGN | Ocugen, Inc. | -2.56% | 8.74 | 0.0% | $968.48m | |
| AMGN | Amgen, Inc. | 2.62% | 227.73 | 1.3% | $602.23m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.71% | 461.57 | 2.7% | $535.67m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 2.02% | 211.98 | 1.9% | $514.02m | |
| GILD | Gilead Sciences, Inc. | 2.20% | 64.62 | 1.0% | $510.98m | |
| ILMN | Illumina, Inc. | -0.19% | 398.85 | 3.5% | $481.19m | |
| BIIB | Biogen, Inc. | 2.71% | 270.71 | 1.7% | $377.15m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.11% | 150.10 | 2.0% | $364.81m | |
| BNGO | BioNano Genomics, Inc. | 3.62% | 7.15 | 0.0% | $275.11m | |
| CRSP | CRISPR Therapeutics AG | -0.73% | 114.65 | 0.6% | $266.37m | |
| EXAS | EXACT Sciences Corp. | 0.51% | 121.64 | 18.4% | $225.25m | |
| SGEN | Seagen Inc. | 2.68% | 149.35 | 5.8% | $209.86m | |
| VXRT | Vaxart, Inc. | 1.69% | 6.02 | 0.0% | $177.29m |
Company Profile
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.